In May 2013, Angelina Jolie revealed in a New York Times opinion piece that she had undergone a preventive double mastectomy because she had a family history of cancer and carried a rare mutation of the BRCA1 gene. Media coverage has been extensive, but it is not obvious what messages the public took from this personal health story.
We conducted a survey with a representative national online panel of 2,572 adults. Participants described their awareness and identified information sources for the Angelina Jolie news story. They also reported their understanding, reactions, perceptions, and subsequent activities related to the story. We asked questions pertaining to personal and societal breast cancer risk and hypothetical questions regarding preventive surgery if the respondent or a family member were in the same position as Ms Jolie. Demographic information was collected, as was family risk for breast and ovarian cancer, and a gauge of numeracy.
While three of four Americans were aware of Angelina Jolie’s double mastectomy, fewer than 10% of respondents had the information necessary to accurately interpret Ms Jolie’s risk of developing cancer relative to a woman unaffected by the BRCA gene mutation. Awareness of the Angelina Jolie story was not associated with improved understanding.
While celebrities can bring heightened awareness to health issues, there is a need for these messages to be accompanied by more purposeful communication efforts to assist the public in understanding and using the complex diagnostic and treatment information that these stories convey.
Genet Med advance online publication 19 December 2013
Cram P, Fendrick AM, Inadomi J, Cowen ME, Carpenter D, Vijan S. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect.Arch Intern Med2003;163:1601–1605.
Kelaher M, Cawson J, Miller J, et al. Use of breast cancer screening and treatment services by Australian women aged 25–44 years following Kylie Minogue’s breast cancer diagnosis.Int J Epid2008;37:1326–1332.
Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, et al.; Hereditary Breast Cancer Clinical Study Group. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.Int J Cancer2008;122:2017–2022.
Den Heijer M, van Asperen CJ, Harris H, et al. International variation in physicians’ attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom.Eur J Cancer. 2013 doi:pii: S0959-8049(13)00359-6. 10.1016/j.ejca.2013.04.025 (Epub ahead of print).
Centers for Disease Control and Prevention (CDC). Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.MMWR Morb Mortal Wkly Rep. 2004;53:603–606.
Bowen DJ, Harris J, Jorgensen CM, Myers MF, Kuniyuki A. Socioeconomic influences on the effects of a genetic testing direct-to-consumer marketing campaign.Public Health Genomics2010;13:131–142.
Kutner M, Greenberg E, Jin Y, Paulsen C. The Health Literacy of America’s Adults: ResultsFrom the 2003 National Assessment of Adult Literacy (NCES 2006–483). U.S. Department of Education, National Center for Education Statistics: Washington, DC, 2006.
Mouchawar J, Hensley-Alford S, Laurion S, et al. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment.Genet Med2005;7:191–197.
Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute: Bethesda, MD.http://seer.cancer.gov/csr/1975_2010/. Accessed 14 September 2013.
Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies.Am J Hum Genet2003;72:1117–1130.
ver historia personal en: www.cerasale.com.ar [dado de baja por la Cancillería Argentina por temas políticos, propio de la censura que rige en nuestro medio]//
weblog.maimonides.edu/farmacia/archives/UM_Informe_Autoevaluacion_FyB.pdf - //
weblog.maimonides.edu/farmacia/archives/0216_Admin_FarmEcon.pdf - //
www.proz.com/kudoz/english_to_spanish/art_literary/523942-key_factors.html - 65k - // www.llave.connmed.com.ar/portalnoticias_vernoticia.php?codigonoticia=17715 // www.frusculleda.com.ar/homepage/espanol/activities_teaching.htm // http://www.on24.com.ar/nota.aspx?idNot=36331 ||